ANTGX:NASDAQ
American Century Non-U.S. IntrinsicValue Fund G Class – ANTGX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 8.13 | -0.19 (-2.28%) | 7.87 - 10.44 | 0.0 |
Market data as of 12:00AM 04/07/25. Quotes are delayed by at least 15 min.
Overview - ANTGX
The investment seeks capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of non-U.S. companies. It may invest in both developed and emerging markets and generally intends to invest across different countries and geographic regions. The fund may invest in common stock and other equity securities that are denominated in foreign currencies and may also invest in foreign securities that are represented in the U.S. securities markets by American Depositary Receipts (ADRs) or similar depositary arrangements.
Growth of $10,000 (10 Years)
| Total Return | 5.75% |
|---|
| Yield (Trailing 12 Mo.) | 3.68% |
|---|
| Expense Ratio | 0.84% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $0.00 |
|---|
| Management Tenure | 6 Years |
|---|
| Fund Inception | 12/06/2018 |
|---|
Trailing Total Returns - ANTGX
as of 03/31/2025
| Timeframe | ANTGX | S&P 500 | Foreign Large Value |
|---|
| 1 Month | 3.32% | -5.63% | 1.74% |
|---|
| 3 Month | 12.05% | -4.27% | 9.60% |
|---|
| Year-to-Date | 12.05% | -4.27% | 9.60% |
|---|
| 1 Year | 6.79% | 8.25% | 9.75% |
|---|
| 3 Year | 10.45% | 9.06% | 7.60% |
|---|
| 5 Year | 14.42% | 18.59% | 13.77% |
|---|
| 10 Year | -- | 12.50% | 5.13% |
|---|
| Since Inception | 5.75% | 10.98% | -- |
|---|
Sector Allocation - ANTGX
as of 03/31/2025
| Basic Materials | | 4.40% |
|---|
| Consumer Cyclical | | 23.00% |
|---|
| Financial Services | | 9.26% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 11.66% |
|---|
| Healthcare | | 14.49% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 9.99% |
|---|
| Energy | | 2.82% |
|---|
| Industrials | | 11.90% |
|---|
| Technology | | 12.47% |
|---|
Asset Allocation - ANTGX
as of 03/31/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 4.61 | 4.61 |
|---|
| Bond | 0.00 | | | 2.02 | 2.02 |
|---|
| Other | 0.00 | | | 0.00 | 0.00 |
|---|
| Foreign Stock | 0.00 | | | 92.57 | 92.57 |
|---|
| Foreign Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Total | 0.00 | | | 99.20 | 99.20 |
|---|
| Cash | 0.00 | | | 0.81 | 0.81 |
|---|
| Total Net Assets | $559.33M |
|---|
| Total Stock Holdings | 52 |
|---|
| Total Bond Holdings | 1 |
|---|
Top Ten Holdings - ANTGX
as of 03/31/2025
| Company | YTD Return | % of Assets |
|---|
| British American Tobacco PLC | -- | 4.52% |
|---|
| Sanofi SA | -- | 4.33% |
|---|
| Samsung Electronics Co Ltd | -- | 4.17% |
|---|
| Roche Holding AG | -- | 4.15% |
|---|
| GSK PLC | -- | 4.07% |
|---|
| Reckitt Benckiser Group PLC | -- | 3.85% |
|---|
| SUMCO Corp | -- | 3.26% |
|---|
| Orange SA | -- | 3.09% |
|---|
| Teleperformance SE | -- | 2.91% |
|---|
| Verallia | -- | 2.90% |
|---|
Valuation & Growth - ANTGX
as of 03/31/2025
| Valuation | ANTGX | Category Range |
|---|
| Price/Earnings | 11.42 | |
|---|
| Price/Book | 1.04 | |
|---|
| Price/Sales | 0.65 | |
|---|
| Price/Cash Flow | 5.48 | |
|---|
| Dividend Yield | 5.96 | |
|---|
| LT Earnings | 9.26 | |
|---|
| Historical Earnings | 9.91 | |
|---|
| Sales Growth | 5.91 | |
|---|
| Cash-Flow Growth | 3.46 | |
|---|
| Book-Value Growth | 5.59 | |
|---|
